[go: up one dir, main page]

RU2013110799A - MEANS FOR PREVENTION AND TREATMENT OF DIABETES - Google Patents

MEANS FOR PREVENTION AND TREATMENT OF DIABETES Download PDF

Info

Publication number
RU2013110799A
RU2013110799A RU2013110799/15A RU2013110799A RU2013110799A RU 2013110799 A RU2013110799 A RU 2013110799A RU 2013110799/15 A RU2013110799/15 A RU 2013110799/15A RU 2013110799 A RU2013110799 A RU 2013110799A RU 2013110799 A RU2013110799 A RU 2013110799A
Authority
RU
Russia
Prior art keywords
diabetes
prevention
treatment
afobazole
ethylthio
Prior art date
Application number
RU2013110799/15A
Other languages
Russian (ru)
Other versions
RU2597848C2 (en
Inventor
Сергей Борисович Середенин
Рита Ушеровна Островская
Татьяна Александровна Воронина
Николай Николаевич Золотов
Милада Альнордовна Яркова
Андрей Дмитриевич Дурнев
Original Assignee
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук filed Critical Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Российской академии медицинских наук
Priority to RU2013110799/15A priority Critical patent/RU2597848C2/en
Publication of RU2013110799A publication Critical patent/RU2013110799A/en
Application granted granted Critical
Publication of RU2597848C2 publication Critical patent/RU2597848C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Применение афобазола, 5-этокси-2-[2-(морфолино)этилтио]-бензимидазола дигидрохлорида, в качестве средства для профилактики и лечения диабета.2. Применение основного метаболита афобазола, 2-[2-(3-оксоморфолин-4-ил)этилтио]-5-этоксибензимидазола, в качестве средства для профилактики и лечения диабета.1. The use of afobazole, 5-ethoxy-2- [2- (morpholino) ethylthio] benzimidazole dihydrochloride, as a means for the prevention and treatment of diabetes. 2. The use of the main metabolite of afobazole, 2- [2- (3-oxomorpholin-4-yl) ethylthio] -5-ethoxybenzimidazole, as a means for the prevention and treatment of diabetes.

Claims (2)

1. Применение афобазола, 5-этокси-2-[2-(морфолино)этилтио]-бензимидазола дигидрохлорида, в качестве средства для профилактики и лечения диабета.1. The use of afobazole, 5-ethoxy-2- [2- (morpholino) ethylthio] benzimidazole dihydrochloride, as a means for the prevention and treatment of diabetes. 2. Применение основного метаболита афобазола, 2-[2-(3-оксоморфолин-4-ил)этилтио]-5-этоксибензимидазола, в качестве средства для профилактики и лечения диабета. 2. The use of the main metabolite of afobazole, 2- [2- (3-oxomorpholin-4-yl) ethylthio] -5-ethoxybenzimidazole, as a means for the prevention and treatment of diabetes.
RU2013110799/15A 2013-03-12 2013-03-12 Drug for prevention and treatment of diabetes RU2597848C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013110799/15A RU2597848C2 (en) 2013-03-12 2013-03-12 Drug for prevention and treatment of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013110799/15A RU2597848C2 (en) 2013-03-12 2013-03-12 Drug for prevention and treatment of diabetes

Publications (2)

Publication Number Publication Date
RU2013110799A true RU2013110799A (en) 2014-09-20
RU2597848C2 RU2597848C2 (en) 2016-09-20

Family

ID=51583378

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013110799/15A RU2597848C2 (en) 2013-03-12 2013-03-12 Drug for prevention and treatment of diabetes

Country Status (1)

Country Link
RU (1) RU2597848C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2649134C1 (en) * 2017-01-17 2018-03-29 Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Means for reduction of glycoprotein-p functional activity and expression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090325975A1 (en) * 2005-07-15 2009-12-31 Helmut H Buschmann Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain

Also Published As

Publication number Publication date
RU2597848C2 (en) 2016-09-20

Similar Documents

Publication Publication Date Title
MX381417B (en) GLUCOSIDASE INHIBITORS.
EA201600091A1 (en) 4-MEMBER RING CARBOXAMIDES APPLIED AS NEMATOCIDES
UY34765A (en) NEW COMPOUNDS.
EA201401054A1 (en) N-CYCLILAMIDES AS NEMATOCIDES
CL2014001765A1 (en) Process for the manufacture of 1- [2- (2,4-dimethylphenylsulfanyl) phenyl] piperazine.
CR20150509A (en) USEFUL NAFTIRIDINE DERIVATIVES AS ANTAGONISTS OF THE ALFA-V-BETA-6 INTEGRINE
UY34591A (en) IMIDAZOPIRROLIDINONA COMPOUNDS
MX373866B (en) HETEROCYCLIC AMIDES AS KINASE INHIBITORS.
EA201792471A1 (en) BIGETEROARRYNY COMPOUNDS AND THEIR APPLICATIONS
EA201591805A1 (en) OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120
MX377357B (en) COMPOUNDS FOR OPTICALLY ACTIVE DEVICES.
EA201591349A1 (en) METHOD OF OBTAINING VORTIOXETIN
LT2925324T (en) TRANS-4- {2- [4- (2,3-DICHLOROPHENYL) -PIPERAZIN-1-IL] -ETHYL} -N, N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR THE TREATMENT OF PRIMARY NEGATIVE SYMPTOMENY SYMPTOMS
AR128158A2 (en) HETEROCYCLIC COMPOUND
CL2015002358A1 (en) Bicyclic compounds.
EA201591915A1 (en) COMPOUNDS OF PHENOXYETHYL DIHYDRO-1H-IZOHINOLINA
EA201491227A1 (en) NEW MORFOLINIL DERIVATIVES SUITABLE FOR USING AS MOGAT-2 INHIBITORS
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
HRP20181799T1 (en) OPTIMIZED PHARMACEUTICAL FORMULA, INTENDED FOR THE TREATMENT OF INFLAMMATORY INFLAMMATORY CHANGE
UY34677A (en) IMIDAZOPIRIDAZINAS REPLACED
MX379401B (en) QUINOLINE CARBOXAMIDES FOR USE IN THE TREATMENT OF LEUKEMIA.
UY4242Q (en) TABLE
TR201905436T4 (en) New ep4 agonists as therapeutic compounds.
EA201690914A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
RU2013110799A (en) MEANS FOR PREVENTION AND TREATMENT OF DIABETES

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant